HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT07551882

Oxytocin Plus Self-compassion Training in Borderline Personality Disorder

This study is recruiting. It focuses on personality disorders and currently lists participation information in Spain.

Personality disorders, Self-compassion Training (SCT) Plus Intranasal Oxytocin, ...DrugFrom 18 Years to 50 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 50 years.

Listed locations
Barcelona, SpainSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 10, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
80
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Spain
Age range
From 18 Years to 50 Years
Official registry ID
NCT07551882
Official title
Efficacy of Oxytocin Plus Self-compassion Training Combination in Patients With Borderline Personality Disorder

Want help reviewing this study?

Loading the security check...
Study ID: NCT07551882. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Barcelona

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Self-compassion Training (SCT) Plus Intranasal Oxytocin; Self-compassion Training (SCT) Plus Intranasal Placebo

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Intranasal Oxytocin (IN-OXT) and Intranasal Placebo.

Who can participate?

Listed age limits: 18 years to 50 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
RecruitingEUCTR 2022-003670-22

Controlled and randomized clinical trial to evaluate the efficacy of the combination of oxytocin plus self-compassion training in patients with Borderline Personality Disorder Ensayo clínico controlado y aleatorizado para evaluar la eficacia de la combinación de oxitocina más entrenamiento en autocompasión en pacientes con Trastorno Límite de Personalidad

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.